146 related articles for article (PubMed ID: 30324788)
21. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
Panzer JA; Anand R; Dalmau J; Lynch DR
J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
[TBL] [Abstract][Full Text] [Related]
22. [Autoimmune pathology in neuropaediatrics: what aspects have really undergone a change].
Cantarin-Extremera V
Rev Neurol; 2017 May; 64(s03):S39-S44. PubMed ID: 28524218
[TBL] [Abstract][Full Text] [Related]
23. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis.
Mathew RM; Vandenberghe R; Garcia-Merino A; Yamamoto T; Landolfi JC; Rosenfeld MR; Rossi JE; Thiessen B; Dropcho EJ; Dalmau J
Neurology; 2007 Mar; 68(12):900-5. PubMed ID: 17151337
[TBL] [Abstract][Full Text] [Related]
24. An update on opsoclonus.
Wong A
Curr Opin Neurol; 2007 Feb; 20(1):25-31. PubMed ID: 17215685
[TBL] [Abstract][Full Text] [Related]
25. REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis.
Compta Y; Iranzo A; Santamaría J; Casamitjana R; Graus F
Sleep; 2007 Jun; 30(6):767-9. PubMed ID: 17580598
[TBL] [Abstract][Full Text] [Related]
26. Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature.
Weizman DA; Leong WL
J Surg Oncol; 2004 Sep; 87(3):143-5. PubMed ID: 15334643
[TBL] [Abstract][Full Text] [Related]
27. Upbeat nystagmus in anti-Ma2 encephalitis.
Garcia-Reitboeck P; Thompson G; Johns P; Al Wahab Y; Omer S; Griffin C
Pract Neurol; 2014 Feb; 14(1):36-8. PubMed ID: 24043843
[TBL] [Abstract][Full Text] [Related]
28. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
29. Neurosarcoidosis with diencephalitis and anti-Ma2 antibodies.
Desestret V; Didelot A; Meyronet D; Bruyas A; Jouvet A; Honnorat J
Neurology; 2010 Mar; 74(9):772-4. PubMed ID: 20194918
[No Abstract] [Full Text] [Related]
30. Paraneoplastic opsoclonus myoclonus with autoantibodies to glutamic acid decarboxylase.
Lamotte G; Danaila TC; Jaillon-Rivière V; Hitier M; Defer GL
Rev Neurol (Paris); 2014 Jan; 170(1):50-1. PubMed ID: 24139240
[No Abstract] [Full Text] [Related]
31. [Paraneoplastic cerebellar degeneration associated with anti-Ma2 antibodies].
Ameneiros-Lago E; Fernández-Fernández FJ; Lijó-Carballeda C
Med Clin (Barc); 2016 Nov; 147(10):e55-e56. PubMed ID: 27650210
[No Abstract] [Full Text] [Related]
32. Opsoclonus: clinical and immunological features.
Jen JC; Lopez I; Baloh RW
J Neurol Sci; 2012 Sep; 320(1-2):61-5. PubMed ID: 22818114
[TBL] [Abstract][Full Text] [Related]
33. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
[TBL] [Abstract][Full Text] [Related]
34. An uncommon paraneoplastic Ri-positive opsoclonus-myoclonus-like syndrome and stiff-person syndrome with elevated glutamate/GABA ratio in the cerebrospinal fluid after breast cancer.
Thümen A; Moser A
J Neurol; 2010 Jul; 257(7):1215-7. PubMed ID: 20177693
[No Abstract] [Full Text] [Related]
35. [Neuroimmunological diseases associated with VGKC complex antibodies].
Watanabe O
Nihon Rinsho; 2013 May; 71(5):915-20. PubMed ID: 23777104
[TBL] [Abstract][Full Text] [Related]
36. Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and Immunopathology.
Williams JP; Carlson NG; Greenlee JE
Semin Neurol; 2018 Jun; 38(3):267-277. PubMed ID: 30011408
[TBL] [Abstract][Full Text] [Related]
37. Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes.
Murphy SM; Khan U; Alifrangis C; Hazell S; Hrouda D; Blake J; Ball J; Gabriel C; Markarian P; Rees J; Karim A; Seckl MJ; Lunn MP; Reilly MM
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):232-3. PubMed ID: 21205983
[TBL] [Abstract][Full Text] [Related]
38. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
39. [Paraneoplastic neurological autoimmune diseases].
Voltz R
Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
[No Abstract] [Full Text] [Related]
40. Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes.
Tampoia M; Zucano A; Antico A; Giometto B; Bonaguri C; Alessio MG; Radice A; Platzgummer S; Bizzaro N
Immunol Invest; 2010 Jan; 39(2):186-95. PubMed ID: 20136624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
